Role of hormone-sensitive lipase in leptin-promoted fat loss and glucose lowering

Mikio Takanashi, Yoshino Taira, Sachiko Okazaki, Satoru Takase, Takeshi Kimura, Cheng Cheng Li, Peng Fei Xu, Akari Noda, Ichiro Sakata, Hidetoshi Kumagai, Yuichi Ikeda, Yoko Iizuka, Naoya Yahagi, Hitoshi Shimano, Jun Ichi Osuga, Shun Ishibashi, Takashi Kadowaki, Hiroaki Okazaki

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Aim: Myriad biological effects of leptin may lead to broad therapeutic applications for various metabolic diseases, including diabetes and its complications; however, in contrast to its anorexic effect, the molecular mechanisms underlying adipopenic and glucose-lowering effects of leptin have not been fully understood. Here we aim to clarify the role of hormone-sensitive lipase (HSL) in leptin’s action. Methods: Wild-type (WT) and HSL-deficient (HSLKO) mice were made hyperleptinemic by two commonly-used methods: adenovirus-mediated overexpression of leptin and continuous subcutaneous infusion of leptin by osmotic pumps. The amount of food intake, body weights, organ weights, and parameters of glucose and lipid metabolism were measured. Results: Hyperleptinemia equally suppressed the food intake in WT and HSLKO mice. On the other hand, leptin-mediated fat loss and glucose-lowering were significantly blunted in the absence of HSL when leptin was overexpressed by recombinant adenovirus carrying leptin. By osmotic pumps, the fat-losing and glucose-lowering effects of leptin were milder due to lower levels of hyperleptinemia; although the difference between WT and HSLKO mice did not reach statistical significance, HSLKO mice had a tendency to retain more fat than WT mice in the face of hyperleptinemia. Conclusions: We clarify for the first time the role of HSL in leptin’s effect using a genetic model: leptin-promoted fat loss and glucose-lowering are at least in part mediated via HSL-mediated lipolysis. Further studies to define the pathophysiological role of adipocyte lipases in leptin action may lead to a new therapeutic approach to circumvent leptin resistance.

Original languageEnglish (US)
Pages (from-to)1105-1116
Number of pages12
JournalJournal of Atherosclerosis and Thrombosis
Volume24
Issue number11
DOIs
StatePublished - 2017

Fingerprint

Sterol Esterase
Leptin
Fats
Glucose
Adenoviridae
Eating
Pumps
Subcutaneous Infusions
Organ Size
Lipolysis
Genetic Models
Metabolic Diseases
Diabetes Complications
Medical problems
Lipase
Lipid Metabolism
Adipocytes

Keywords

  • Hypoglycemia
  • Leptin
  • Leptin resistance
  • Lipase
  • Lipolysis

ASJC Scopus subject areas

  • Internal Medicine
  • Cardiology and Cardiovascular Medicine
  • Biochemistry, medical

Cite this

Takanashi, M., Taira, Y., Okazaki, S., Takase, S., Kimura, T., Li, C. C., ... Okazaki, H. (2017). Role of hormone-sensitive lipase in leptin-promoted fat loss and glucose lowering. Journal of Atherosclerosis and Thrombosis, 24(11), 1105-1116. https://doi.org/10.5551/jat.39552

Role of hormone-sensitive lipase in leptin-promoted fat loss and glucose lowering. / Takanashi, Mikio; Taira, Yoshino; Okazaki, Sachiko; Takase, Satoru; Kimura, Takeshi; Li, Cheng Cheng; Xu, Peng Fei; Noda, Akari; Sakata, Ichiro; Kumagai, Hidetoshi; Ikeda, Yuichi; Iizuka, Yoko; Yahagi, Naoya; Shimano, Hitoshi; Osuga, Jun Ichi; Ishibashi, Shun; Kadowaki, Takashi; Okazaki, Hiroaki.

In: Journal of Atherosclerosis and Thrombosis, Vol. 24, No. 11, 2017, p. 1105-1116.

Research output: Contribution to journalArticle

Takanashi, M, Taira, Y, Okazaki, S, Takase, S, Kimura, T, Li, CC, Xu, PF, Noda, A, Sakata, I, Kumagai, H, Ikeda, Y, Iizuka, Y, Yahagi, N, Shimano, H, Osuga, JI, Ishibashi, S, Kadowaki, T & Okazaki, H 2017, 'Role of hormone-sensitive lipase in leptin-promoted fat loss and glucose lowering', Journal of Atherosclerosis and Thrombosis, vol. 24, no. 11, pp. 1105-1116. https://doi.org/10.5551/jat.39552
Takanashi, Mikio ; Taira, Yoshino ; Okazaki, Sachiko ; Takase, Satoru ; Kimura, Takeshi ; Li, Cheng Cheng ; Xu, Peng Fei ; Noda, Akari ; Sakata, Ichiro ; Kumagai, Hidetoshi ; Ikeda, Yuichi ; Iizuka, Yoko ; Yahagi, Naoya ; Shimano, Hitoshi ; Osuga, Jun Ichi ; Ishibashi, Shun ; Kadowaki, Takashi ; Okazaki, Hiroaki. / Role of hormone-sensitive lipase in leptin-promoted fat loss and glucose lowering. In: Journal of Atherosclerosis and Thrombosis. 2017 ; Vol. 24, No. 11. pp. 1105-1116.
@article{6ab41b87a8224f33921c2a0da730b010,
title = "Role of hormone-sensitive lipase in leptin-promoted fat loss and glucose lowering",
abstract = "Aim: Myriad biological effects of leptin may lead to broad therapeutic applications for various metabolic diseases, including diabetes and its complications; however, in contrast to its anorexic effect, the molecular mechanisms underlying adipopenic and glucose-lowering effects of leptin have not been fully understood. Here we aim to clarify the role of hormone-sensitive lipase (HSL) in leptin’s action. Methods: Wild-type (WT) and HSL-deficient (HSLKO) mice were made hyperleptinemic by two commonly-used methods: adenovirus-mediated overexpression of leptin and continuous subcutaneous infusion of leptin by osmotic pumps. The amount of food intake, body weights, organ weights, and parameters of glucose and lipid metabolism were measured. Results: Hyperleptinemia equally suppressed the food intake in WT and HSLKO mice. On the other hand, leptin-mediated fat loss and glucose-lowering were significantly blunted in the absence of HSL when leptin was overexpressed by recombinant adenovirus carrying leptin. By osmotic pumps, the fat-losing and glucose-lowering effects of leptin were milder due to lower levels of hyperleptinemia; although the difference between WT and HSLKO mice did not reach statistical significance, HSLKO mice had a tendency to retain more fat than WT mice in the face of hyperleptinemia. Conclusions: We clarify for the first time the role of HSL in leptin’s effect using a genetic model: leptin-promoted fat loss and glucose-lowering are at least in part mediated via HSL-mediated lipolysis. Further studies to define the pathophysiological role of adipocyte lipases in leptin action may lead to a new therapeutic approach to circumvent leptin resistance.",
keywords = "Hypoglycemia, Leptin, Leptin resistance, Lipase, Lipolysis",
author = "Mikio Takanashi and Yoshino Taira and Sachiko Okazaki and Satoru Takase and Takeshi Kimura and Li, {Cheng Cheng} and Xu, {Peng Fei} and Akari Noda and Ichiro Sakata and Hidetoshi Kumagai and Yuichi Ikeda and Yoko Iizuka and Naoya Yahagi and Hitoshi Shimano and Osuga, {Jun Ichi} and Shun Ishibashi and Takashi Kadowaki and Hiroaki Okazaki",
year = "2017",
doi = "10.5551/jat.39552",
language = "English (US)",
volume = "24",
pages = "1105--1116",
journal = "Journal of Atherosclerosis and Thrombosis",
issn = "1340-3478",
publisher = "Japan Atherosclerosis Society",
number = "11",

}

TY - JOUR

T1 - Role of hormone-sensitive lipase in leptin-promoted fat loss and glucose lowering

AU - Takanashi, Mikio

AU - Taira, Yoshino

AU - Okazaki, Sachiko

AU - Takase, Satoru

AU - Kimura, Takeshi

AU - Li, Cheng Cheng

AU - Xu, Peng Fei

AU - Noda, Akari

AU - Sakata, Ichiro

AU - Kumagai, Hidetoshi

AU - Ikeda, Yuichi

AU - Iizuka, Yoko

AU - Yahagi, Naoya

AU - Shimano, Hitoshi

AU - Osuga, Jun Ichi

AU - Ishibashi, Shun

AU - Kadowaki, Takashi

AU - Okazaki, Hiroaki

PY - 2017

Y1 - 2017

N2 - Aim: Myriad biological effects of leptin may lead to broad therapeutic applications for various metabolic diseases, including diabetes and its complications; however, in contrast to its anorexic effect, the molecular mechanisms underlying adipopenic and glucose-lowering effects of leptin have not been fully understood. Here we aim to clarify the role of hormone-sensitive lipase (HSL) in leptin’s action. Methods: Wild-type (WT) and HSL-deficient (HSLKO) mice were made hyperleptinemic by two commonly-used methods: adenovirus-mediated overexpression of leptin and continuous subcutaneous infusion of leptin by osmotic pumps. The amount of food intake, body weights, organ weights, and parameters of glucose and lipid metabolism were measured. Results: Hyperleptinemia equally suppressed the food intake in WT and HSLKO mice. On the other hand, leptin-mediated fat loss and glucose-lowering were significantly blunted in the absence of HSL when leptin was overexpressed by recombinant adenovirus carrying leptin. By osmotic pumps, the fat-losing and glucose-lowering effects of leptin were milder due to lower levels of hyperleptinemia; although the difference between WT and HSLKO mice did not reach statistical significance, HSLKO mice had a tendency to retain more fat than WT mice in the face of hyperleptinemia. Conclusions: We clarify for the first time the role of HSL in leptin’s effect using a genetic model: leptin-promoted fat loss and glucose-lowering are at least in part mediated via HSL-mediated lipolysis. Further studies to define the pathophysiological role of adipocyte lipases in leptin action may lead to a new therapeutic approach to circumvent leptin resistance.

AB - Aim: Myriad biological effects of leptin may lead to broad therapeutic applications for various metabolic diseases, including diabetes and its complications; however, in contrast to its anorexic effect, the molecular mechanisms underlying adipopenic and glucose-lowering effects of leptin have not been fully understood. Here we aim to clarify the role of hormone-sensitive lipase (HSL) in leptin’s action. Methods: Wild-type (WT) and HSL-deficient (HSLKO) mice were made hyperleptinemic by two commonly-used methods: adenovirus-mediated overexpression of leptin and continuous subcutaneous infusion of leptin by osmotic pumps. The amount of food intake, body weights, organ weights, and parameters of glucose and lipid metabolism were measured. Results: Hyperleptinemia equally suppressed the food intake in WT and HSLKO mice. On the other hand, leptin-mediated fat loss and glucose-lowering were significantly blunted in the absence of HSL when leptin was overexpressed by recombinant adenovirus carrying leptin. By osmotic pumps, the fat-losing and glucose-lowering effects of leptin were milder due to lower levels of hyperleptinemia; although the difference between WT and HSLKO mice did not reach statistical significance, HSLKO mice had a tendency to retain more fat than WT mice in the face of hyperleptinemia. Conclusions: We clarify for the first time the role of HSL in leptin’s effect using a genetic model: leptin-promoted fat loss and glucose-lowering are at least in part mediated via HSL-mediated lipolysis. Further studies to define the pathophysiological role of adipocyte lipases in leptin action may lead to a new therapeutic approach to circumvent leptin resistance.

KW - Hypoglycemia

KW - Leptin

KW - Leptin resistance

KW - Lipase

KW - Lipolysis

UR - http://www.scopus.com/inward/record.url?scp=85032899714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032899714&partnerID=8YFLogxK

U2 - 10.5551/jat.39552

DO - 10.5551/jat.39552

M3 - Article

VL - 24

SP - 1105

EP - 1116

JO - Journal of Atherosclerosis and Thrombosis

JF - Journal of Atherosclerosis and Thrombosis

SN - 1340-3478

IS - 11

ER -